Gert-Jan van Baaren

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

Kim Broekhuijsen, Gert-Jan van Baaren, Maria G. van Pampus et al. · The Lancet · 2015 · 191 citations

Hypertension, Gestational Hypertension, Pregnancy Disorders +11

Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial

Mieke Ten Eikelder, Katrien Oude Rengerink, Marta Jozwiak et al. · The Lancet · 2016 · 121 citations

Patient Safety, Oral Misoprostol, Gynecology +6

The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women

Merel Bruijn, Esmé Kamphuis, Irène Hoesli et al. · American Journal of Obstetrics and Gynecology · 2016 · 70 citations

Uterine Fibroids, Cervical Cancer, Cervical Health +9

Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor

Gert-Jan van Baaren, Jolande Vis, William A. Grobman et al. · American Journal of Obstetrics and Gynecology · 2013 · 43 citations

Cost-effectiveness Analysis, Health Economics, Cervical Health +12

Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement

Merel Bruijn, Jolande Vis, Femke Wilms et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2016 · 30 citations · Full text

Fertility, Preterm Labor, Medicine +15